Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
| Last: | $1.205 |
|---|---|
| Change Percent: | 6.17% |
| Open: | $1.15 |
| Close: | $1.135 |
| High: | $1.23 |
| Low: | $1.15 |
| Volume: | 69,106 |
| Last Trade Date Time: | 02/27/2026 12:39:25 pm |
| Market Cap: | $40,570,396 |
|---|---|
| Float: | 24,688,117 |
| Insiders Ownership: | 4.16% |
| Institutions: | 15 |
| Short Percent: | N/A |
| Industry: | Medical Equipment & Supplies |
| Sector: | Healthcare |
| Website: | https://www.elutia.com |
| Country: | US |
| City: | Gaithersburg |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Elutia Inc. (NASDAQ: ELUT).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.